edwards.com - שווי חברה להכנסות EW

Despite labor shortages and regulatory pressure, Edwards Lifesciences (EW) maintains its leadership. The company's enterprise value-to-revenue multiple reflects the market reaction, with the indicator currently at 8373.45. Dominance in cardiac surgery and physician training create a resilient ecosystem, while the high clinical significance of its products provides the business with exceptional pricing power.
edwards.com - פילוחים אנליטיים ומדדי מפתח (EW)

To determine the fair value of the asset, use the enterprise value-to-revenue ratio, which excludes the impact of debt load. This ratio measures the market valuation of one dollar of sales, while the EV/Sales multiple trajectory reflects price sensitivity to credit cycles. High values are justified for Edwards Lifesciences (EW) due to patent protection and the complexity of cardiac equipment certification.